By BEX Staff for AZBEX
The University of Arizona recently announced two major funding awards for its UA Center for Advanced Molecular and Immunological Therapies in the Phoenix Bioscience Core.
CAMI is planned as a 293KSF building dedicated to supporting “research to catalyze the next generation of precision health care treatments,” according to a UA announcement.
UA describes the project by saying, “CAMI will serve as the anchor for an innovation district that aims to differentiate Phoenix from other emerging life sciences hubs, establishing the Phoenix Bioscience Core as a center of cellular and gene-based therapy research, startup activity and corporate engagement.”
In the first funding award announcement, UA said, the project “received a strong vote of support from Arizona Gov. Doug Ducey, who designated $150M in new funding for the Phoenix-based center.”
The second announcement disclosed the award of $10M from the Steele Foundation that includes the first private funding for CAMI.
According to the announcement, “The Steele Foundation gift will create the Daniel Cracchiolo Institute for Pediatric Autoimmune Disease Research at the Steele Children’s Research Center and provide financial support for graduate students, postdoctoral researchers and faculty members.
“Of the gift, $2M is designated for CAMI, to be located at the Phoenix Bioscience Core in downtown Phoenix. CAMI will serve as a hub to advance knowledge of the immunology of autoimmune conditions, inflammation, cancers and infectious diseases to develop novel strategies for the diagnosis, prevention and treatment of diseases.”
The Steele Foundation has, to date, provided approximately $21M to support medical research and learning programs at UA. The newly announced award is the Foundation’s largest gift so far.
